RVL Pharmaceuticals plc Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2023-08-31: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2023-08-18; Total offering amount $5,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2023-08-31 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2023-08-18 | $5,000,000 | $5,000,000 | $0 | 1 |